Back

Systemic administration of hEPSC-derived Trophoblast stem cells for cardiac regeneration

29 August 2025 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Innovative strategies for cardiac and vascular regeneration Stem Cells, Cell Cycle, Cell Senescence, Cell Death ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Song-Yan Liao

The University of Hong Kong, Hong Kong (Hong Kong)

6 More presentations in this session

Presentation thumbnail
A novel strategy by pharmacological reprogramming reverses endothelial senescence and improves vascular regeneration
Doctor K. Kalies (Halle, DE)
Abstract Slides Video
Presentation thumbnail
MicroRNA-33 inhibition ameliorates muscular dystrophy by enhancing skeletal muscle regeneration
Doctor H. Kojima (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Cardiac organoids as regenerative therapy in a preclinical model of acute myocardial infarction-Corrected version
Mrs M. Kalil (Badalona, ES)
Abstract Slides Video
Presentation thumbnail
MicroRNA-762 inhibition enhances angiogenesis and vascular regeneration by targeting XAF1 and CMPK2
Miss L. Hehl (Halle, DE)
Abstract Slides Video
Presentation thumbnail
Magnetic nanovesicle-mediated mRNA delivery targets injured cardiac tissue and rescues ischemic injury with low immunogenicity
Ms D. Mun (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Innovative strategies for cardiac and vascular regeneration

The Event

Event poster

ESC Congress 2025

29 August 2025 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Exploring the interactions between cardiomyocytes and endothelial cells to induce cardiac revascularization and regeneration
thumbnail
Congress Presentation
Extracellular vesicles from second trimester human amniotic fluid as candidate therapeutics against myocardial injury
thumbnail
Congress Presentation
In vitro platform to model anthracycline-induced cardiotoxicity and evaluate cardioprotective agents in human -induced pluripotent stem cells-derived cardiomyocytes

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources